bioAffinity Technologies Advances CyPath Lung for Cancer Surveillance
SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...
laboratory developed test
Advertisement
Innogen Gains PIC/S GMP Certification for Efsubaglutide
Shanghai, China – August 4, 2026 Innogen Pharmaceuticals has announced that its Efsubaglutide alfa manufacturing facility in Suzhou has...
CND Life Sciences Secures Growth Funding for Syn-One Test
Scottsdale, Arizona & Boca Raton, Florida, August 4, 2026 CND Life Sciences has announced the successful completion of a...
Verici Dx Achieves Nationwide Access Following New York State Approval
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
Plus Therapeutics Expands CNSide Cancer Assay Access Nationwide
HOUSTON, December 11, 2025 — Plus Therapeutics announced that its subsidiary CNSide Diagnostics, LLC has secured new state laboratory...
Advertisement
